Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2017

01-10-2017 | Original Article

Tubercular Intestinal Strictures Show a Poor Response to Anti-Tuberculous Therapy

Authors: Piyush Aggarwal, Saurabh Kedia, Raju Sharma, Sawan Bopanna, Kumble Seetharama Madhusudhan, Dawesh P. Yadav, Sandeep Goyal, Saransh Jain, Venigalla Pratap Mouli, Prasenjit Das, Siddhartha Dattagupta, Govind Makharia, Vineet Ahuja

Published in: Digestive Diseases and Sciences | Issue 10/2017

Login to get access

Abstract

Background

The literature on resolution of intestinal strictures in patients with intestinal tuberculosis (ITB) after anti-tuberculous therapy (ATT) is sparse and ambivalent. We aimed to assess the frequency of stricture resolution after ATT and its predictors.

Methods

This ambispective cohort study included consecutive ITB patients with strictures who received ATT for ≥6 months and were on regular follow-up between January 2004 and December 2015. Resolution of stricture was assessed at the end of ATT by endoscopy/radiology.

Results

Of 286 patients, 128 had strictures, and 106 were finally included (63 males, median age 35 years). The stricture location was distal ileum/ileocecal in 52 (49.1%), colon in 37 (34.9%), ileocolonic in 4 (3.8%), proximal small bowel in 10 (9.4%), and gastroduodenal in 4 (3.8%) patients. Although all patients demonstrated mucosal healing (indicating resolution of active infection), stricture resolution occurred only in 25/106 (23.6%) patients. Symptoms pertaining to stricture (pain abdomen/recurrent SAIO) were present in 104/106 (98%) patients, and after a median of 6 (6–9) months of ATT, these symptoms resolved only in half, 88% (22/25) in patients with stricture resolution and 38% (30/79) in patients with persistent strictures. Colonic strictures had the least resolution (5.4%) followed by proximal small intestinal (20%) and distal ileal/ileocecal (36.5%). Although not statistically significant, stricture resolution was less frequent in patients with multiple strictures, longer strictures (>3 cm), and strictures in which scope was not negotiable prior to ATT.

Conclusion

Only one-fourth of ITB patients with strictures show resolution of stricture following ATT. The resolution of strictures is dependent on disease location, and majority of them exhibit symptoms pertaining to stricture even after ATT.
Literature
1.
go back to reference Kedia S, Sharma R, Nagi B, et al. Computerized tomography-based predictive model for differentiation of Crohn’s disease from intestinal tuberculosis. Indian J Gastroenterol. 2015;34:135–143.CrossRefPubMed Kedia S, Sharma R, Nagi B, et al. Computerized tomography-based predictive model for differentiation of Crohn’s disease from intestinal tuberculosis. Indian J Gastroenterol. 2015;34:135–143.CrossRefPubMed
2.
go back to reference Smith A. Streptomycin in treatment of tuberculosis: Council on Pharmacy and Chemistry. JAMA. 1948;138:548–593. Smith A. Streptomycin in treatment of tuberculosis: Council on Pharmacy and Chemistry. JAMA. 1948;138:548–593.
3.
go back to reference Sweany HC, Lichtenstein MR, et al. Streptomycin treatment of tuberculous enterocolitis; results in 30 cases. Am Rev Tuberc. 1949;60:576–588. PubMed PMID: 15392762.PubMed Sweany HC, Lichtenstein MR, et al. Streptomycin treatment of tuberculous enterocolitis; results in 30 cases. Am Rev Tuberc. 1949;60:576–588. PubMed PMID: 15392762.PubMed
4.
go back to reference Mason EF, Kridelbaugh WE. Streptomycin in the treatment of tuberculous enteritis; a report of 33 cases. Am J Med Sci. 1949;217:28–46.CrossRefPubMed Mason EF, Kridelbaugh WE. Streptomycin in the treatment of tuberculous enteritis; a report of 33 cases. Am J Med Sci. 1949;217:28–46.CrossRefPubMed
5.
go back to reference Pimparkar BD. Abdominal tuberculosis. J Assoc Physicians India. 1977;25:801–811.PubMed Pimparkar BD. Abdominal tuberculosis. J Assoc Physicians India. 1977;25:801–811.PubMed
6.
go back to reference Jordan GL Jr, De Bakey ME. Complications of tuberculous enteritis occurring during antimicrobial therapy. AMA Arch Surg. 1954;69:688–693.CrossRefPubMed Jordan GL Jr, De Bakey ME. Complications of tuberculous enteritis occurring during antimicrobial therapy. AMA Arch Surg. 1954;69:688–693.CrossRefPubMed
8.
go back to reference Mukewar S, Mukewar S, Ravi R, Prasad A, Dua KS. Colon tuberculosis: endoscopic features and prospective endoscopic follow-up after anti-tuberculosis treatment. Clin Transl Gastroenterol. 2012;3:e24.CrossRefPubMedPubMedCentral Mukewar S, Mukewar S, Ravi R, Prasad A, Dua KS. Colon tuberculosis: endoscopic features and prospective endoscopic follow-up after anti-tuberculosis treatment. Clin Transl Gastroenterol. 2012;3:e24.CrossRefPubMedPubMedCentral
9.
go back to reference Hara AK, Leighton JA, Heigh RI, et al. Crohn disease of the small bowel: preliminary comparison among CT enterography, capsule endoscopy, small-bowel follow-through, and ileoscopy. Radiology. 2006;238:128–134.CrossRefPubMed Hara AK, Leighton JA, Heigh RI, et al. Crohn disease of the small bowel: preliminary comparison among CT enterography, capsule endoscopy, small-bowel follow-through, and ileoscopy. Radiology. 2006;238:128–134.CrossRefPubMed
10.
go back to reference Lee SS, Kim AY, Yang SK, et al. Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques. Radiology. 2009;251:751–761.CrossRefPubMed Lee SS, Kim AY, Yang SK, et al. Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques. Radiology. 2009;251:751–761.CrossRefPubMed
11.
go back to reference Krishna S, Kalra N, Singh P, et al. Small-bowel tuberculosis: a comparative study of MR enterography and small-bowel follow-through. AJR Am J Roentgenol. 2016;207:571–577.CrossRefPubMed Krishna S, Kalra N, Singh P, et al. Small-bowel tuberculosis: a comparative study of MR enterography and small-bowel follow-through. AJR Am J Roentgenol. 2016;207:571–577.CrossRefPubMed
13.
go back to reference Paustian F. Tuberculosis of the intestine. In: Bockus HL, ed. Bockus gastroenterology. 5th ed. Philadelphia: Saunders; 1995:3304. Paustian F. Tuberculosis of the intestine. In: Bockus HL, ed. Bockus gastroenterology. 5th ed. Philadelphia: Saunders; 1995:3304.
14.
go back to reference Pratap Mouli V, Munot K, Ananthakrishnan A, et al. Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn’s disease. Aliment Pharmacol Ther. 2017;45:27–36.CrossRefPubMed Pratap Mouli V, Munot K, Ananthakrishnan A, et al. Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn’s disease. Aliment Pharmacol Ther. 2017;45:27–36.CrossRefPubMed
15.
go back to reference Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63:e147–e195.CrossRefPubMed Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63:e147–e195.CrossRefPubMed
16.
go back to reference Rimola J, Planell N, Rodríguez S, et al. Characterization of inflammation and fibrosis in Crohn’s disease lesions by magnetic resonance imaging. Am J Gastroenterol. 2015;110:432–440.CrossRefPubMed Rimola J, Planell N, Rodríguez S, et al. Characterization of inflammation and fibrosis in Crohn’s disease lesions by magnetic resonance imaging. Am J Gastroenterol. 2015;110:432–440.CrossRefPubMed
17.
go back to reference Booya F, Fletcher JG, Huprich JE, et al. Active Crohn disease: CT findings and interobserver agreement for enteric phase CT enterography. Radiology. 2006;241:787–795.CrossRefPubMed Booya F, Fletcher JG, Huprich JE, et al. Active Crohn disease: CT findings and interobserver agreement for enteric phase CT enterography. Radiology. 2006;241:787–795.CrossRefPubMed
18.
go back to reference Bettenworth D, Rieder F. Pathogenesis of intestinal fibrosis in inflammatory bowel disease and perspectives for therapeutic implication. Dig Dis. 2017;35:25–31.CrossRefPubMed Bettenworth D, Rieder F. Pathogenesis of intestinal fibrosis in inflammatory bowel disease and perspectives for therapeutic implication. Dig Dis. 2017;35:25–31.CrossRefPubMed
19.
go back to reference Makharia GK, Ghoshal UC, Ramakrishna BS, et al. Intermittent directly observed therapy for abdominal tuberculosis: a multicenter randomized controlled trial comparing 6 months versus 9 months of therapy. Clin Infect Dis. 2015;61:750–757.CrossRefPubMed Makharia GK, Ghoshal UC, Ramakrishna BS, et al. Intermittent directly observed therapy for abdominal tuberculosis: a multicenter randomized controlled trial comparing 6 months versus 9 months of therapy. Clin Infect Dis. 2015;61:750–757.CrossRefPubMed
20.
go back to reference Misra SP, Misra V, Dwivedi M, Arora JS, Kunwar BK. Tuberculous colonic strictures: impact of dilation on diagnosis. Endoscopy. 2004;36:1099–1103.CrossRefPubMed Misra SP, Misra V, Dwivedi M, Arora JS, Kunwar BK. Tuberculous colonic strictures: impact of dilation on diagnosis. Endoscopy. 2004;36:1099–1103.CrossRefPubMed
Metadata
Title
Tubercular Intestinal Strictures Show a Poor Response to Anti-Tuberculous Therapy
Authors
Piyush Aggarwal
Saurabh Kedia
Raju Sharma
Sawan Bopanna
Kumble Seetharama Madhusudhan
Dawesh P. Yadav
Sandeep Goyal
Saransh Jain
Venigalla Pratap Mouli
Prasenjit Das
Siddhartha Dattagupta
Govind Makharia
Vineet Ahuja
Publication date
01-10-2017
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4727-3

Other articles of this Issue 10/2017

Digestive Diseases and Sciences 10/2017 Go to the issue

UNM Clinical Case Conferences

Crohn’s Disease: Hard to Swallow!

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.